Bicanalicular silicone intubation (Oggel silicone intubation) in patients with aquired lacrimal stenosis.

• Conditions: H04.5; Stenosis and insufficiency of lacrimal passages

• Registration Number: DRKS00010939
• Lead Sponsor: Augenklinik des Universitätsklinikums Ulm

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-08-04
• Study Completion: 2016-10-09
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 82

Inclusion Criteria

Patients with aquired lacrimal stenosis (canalicular stenosis, stenosis in the lacrimal sac, nasolacrimal duct stenosis) were included.

Exclusion Criteria

- other silicone intubation sets ( Rietleng silicone
tube, MiniMonoka tube, monocanalicular intubation)
- silicone intubation based of lacrimal tumors
- inflammation of the lacrimal system
(dacryocystitis, canalicutitis)
- congenital lacrimal stenosis
- underaged patients with aquired lacrimal stenosis
- patients with previous lacrimal surgery
(dacryocystorhinostomy)
- patient with punctal stenosis
- silicone intubation based on lacrimal system
laceration
- patient who died after removal of the silicone tube

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The purpose is the determination of resolution of the main characteristic (epiphora) at the time of silicone tube removal, at the follow up (4 weeks after silicone tube removal) and after one year by use of the patient file of the Department of Ophthalmology, University of Ulm and a mail questionnair to the patients and their ophthalmologists.

Secondary Outcome Measures

Name	Time	Method
The mail questionnaire included question about pre and postoperative symptoms, the time period of symptoms and the risk factors of aquired lacrimal stenosis.